share_log

HC Wainwright & Co. Reiterates Buy on Ikena Oncology, Maintains $11 Price Target

Benzinga ·  Jan 19 20:16

HC Wainwright & Co. analyst Andres Maldonado reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $11 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment